GR3036450T3 - Self-contained transdermal drug delivery device - Google Patents

Self-contained transdermal drug delivery device

Info

Publication number
GR3036450T3
GR3036450T3 GR20010401300T GR20010401300T GR3036450T3 GR 3036450 T3 GR3036450 T3 GR 3036450T3 GR 20010401300 T GR20010401300 T GR 20010401300T GR 20010401300 T GR20010401300 T GR 20010401300T GR 3036450 T3 GR3036450 T3 GR 3036450T3
Authority
GR
Greece
Prior art keywords
drug delivery
delivery device
transdermal drug
self
contained
Prior art date
Application number
GR20010401300T
Other languages
English (en)
Inventor
Gary A Lattin
Tighe M Belden
Andrew J Withell
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GR3036450T3 publication Critical patent/GR3036450T3/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/0075—Disposal of medical waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches
GR20010401300T 1995-03-24 2001-08-27 Self-contained transdermal drug delivery device GR3036450T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/410,203 US5879322A (en) 1995-03-24 1995-03-24 Self-contained transdermal drug delivery device
PCT/US1996/003195 WO1996030077A1 (en) 1995-03-24 1996-03-08 Self-contained transdermal drug delivery device

Publications (1)

Publication Number Publication Date
GR3036450T3 true GR3036450T3 (en) 2001-11-30

Family

ID=23623707

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401300T GR3036450T3 (en) 1995-03-24 2001-08-27 Self-contained transdermal drug delivery device

Country Status (11)

Country Link
US (1) US5879322A (el)
EP (1) EP0817659B1 (el)
JP (1) JPH11503037A (el)
AT (1) ATE201604T1 (el)
DE (1) DE69613113T2 (el)
DK (1) DK0817659T3 (el)
ES (1) ES2159022T3 (el)
GR (1) GR3036450T3 (el)
PT (1) PT817659E (el)
WO (1) WO1996030077A1 (el)
ZA (1) ZA962122B (el)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
IE960375A1 (en) * 1995-06-05 1996-12-11 Alza Corp Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6157858A (en) * 1996-12-26 2000-12-05 Elan Pharma International Limited Device for the delivery of a substance to a subject and improved electrode assembly
AU5337998A (en) * 1996-12-26 1998-07-31 Elan International Services Limited Device for the delivery of a substance to a subject and improved electrode assembly
US5991655A (en) * 1997-03-03 1999-11-23 Drug Delivery Systems, Inc. Iontophoretic drug delivery device and method of manufacturing the same
US8177762B2 (en) 1998-12-07 2012-05-15 C. R. Bard, Inc. Septum including at least one identifiable feature, access ports including same, and related methods
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6548569B1 (en) * 1999-03-25 2003-04-15 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
WO2001015671A2 (en) 1999-08-30 2001-03-08 Tepha, Inc. Flushable disposable polymeric products
US20010041869A1 (en) * 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
IL154838A0 (en) * 2000-09-11 2003-10-31 Alza Corp Transdermal electrotransport device and method for manufacturing same
US7520875B2 (en) * 2001-04-06 2009-04-21 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7496401B2 (en) * 2001-04-06 2009-02-24 Mattioli Engineering Ltd Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7083580B2 (en) * 2001-04-06 2006-08-01 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7010343B2 (en) * 2001-04-06 2006-03-07 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US8574204B2 (en) 2002-10-21 2013-11-05 Angiodynamics, Inc. Implantable medical device for improved placement and adherence in the body
ES2819189T3 (es) 2003-05-08 2021-04-15 Tepha Inc Tejidos y fibras médicos de polihidroxialcanoato
JP2007528853A (ja) * 2003-07-08 2007-10-18 テファ， インコーポレイテッド 徐放性薬物送達のためのポリ−４−ヒドロキシブチレートマトリックス
WO2005004984A1 (en) * 2003-07-14 2005-01-20 Power Paper Ltd. Device and method for the treatment of pilosebaceous disorders
CA2536510C (en) * 2003-08-22 2011-01-18 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
CA2544291C (en) * 2003-10-27 2013-01-08 University Of Basel Transdermal drug delivery method and system
US8366687B2 (en) 2004-01-06 2013-02-05 Angio Dynamics Injection access port with chamfered top hat septum design
US20050271597A1 (en) * 2004-02-13 2005-12-08 Keith Alec D Prostate hypertrophy treatment composition and method
US8277425B2 (en) 2004-03-24 2012-10-02 Navilyst Medical, Inc. Dual lumen port with F-shaped connector
PL1778305T3 (pl) * 2004-08-03 2011-04-29 Tepha Inc Szwy z polihydroksyalkanianów nieulegające zwijaniu się
EP1802258A4 (en) * 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
US8252321B2 (en) * 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP2008528204A (ja) * 2005-01-28 2008-07-31 テファ， インコーポレイテッド ポリ−４−ヒドロキシブチレート粒子を使用した塞栓形成
US8029482B2 (en) 2005-03-04 2011-10-04 C. R. Bard, Inc. Systems and methods for radiographically identifying an access port
EP1858565B1 (en) 2005-03-04 2021-08-11 C.R. Bard, Inc. Access port identification systems and methods
US7947022B2 (en) 2005-03-04 2011-05-24 C. R. Bard, Inc. Access port identification systems and methods
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
US8386029B2 (en) 2005-03-31 2013-02-26 Encore Medical Asset Corporation Apparatus for electrotherapy drug delivery with added impurities
US8147455B2 (en) 2005-04-27 2012-04-03 C. R. Bard, Inc. Infusion apparatuses and methods of use
EP3884989B1 (en) 2005-04-27 2022-07-13 C. R. Bard, Inc. Vascular access port
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
WO2006135785A2 (en) * 2005-06-10 2006-12-21 Medical College Of Georgia Research Institute Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US9550050B2 (en) * 2006-09-25 2017-01-24 MEDIMETRICS Personalized Drug Delivery B.V. Medicament delivery apparatus
US9265912B2 (en) 2006-11-08 2016-02-23 C. R. Bard, Inc. Indicia informative of characteristics of insertable medical devices
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US20100041704A1 (en) * 2007-01-12 2010-02-18 Aberg A K Gunnar Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
US8197844B2 (en) * 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8738137B2 (en) 2007-08-23 2014-05-27 Bioness Inc. System for transmitting electrical current to a bodily tissue
US9757554B2 (en) 2007-08-23 2017-09-12 Bioness Inc. System for transmitting electrical current to a bodily tissue
JP5425077B2 (ja) * 2007-08-23 2014-02-26 バイオネス インコーポレイテッド 体組織に電流を伝送するシステム
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US8075536B2 (en) * 2008-09-09 2011-12-13 Navilyst Medical, Inc. Power injectable port identification
CN102271737B (zh) 2008-10-31 2016-02-17 C·R·巴德股份有限公司 用于提供对患者皮下进入的进入端口
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US8932271B2 (en) 2008-11-13 2015-01-13 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
ES2612830T3 (es) 2008-12-30 2017-05-18 Teva Pharmaceuticals International Gmbh Control electrónico de sistema de administración de fármacos
WO2011014775A1 (en) 2009-07-31 2011-02-03 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
ES2695907T3 (es) 2009-11-17 2019-01-11 Bard Inc C R Puerto de acceso sobremoldeado que incluye características de anclaje e identificación
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
CA2817824A1 (en) 2010-11-23 2012-05-31 Nupathe, Inc. User-activated self-contained co-packaged iontophoretic drug delivery system
USD682416S1 (en) 2010-12-30 2013-05-14 C. R. Bard, Inc. Implantable access port
USD676955S1 (en) 2010-12-30 2013-02-26 C. R. Bard, Inc. Implantable access port
WO2012129237A2 (en) 2011-03-20 2012-09-27 Trustees Of Boston University Therapeutic agent for emphysema and copd
US9480696B2 (en) 2011-05-04 2016-11-01 Trustees Of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2543370A1 (en) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Compositions and Methods for Treating Herpes Simplex Virus
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
WO2013071049A1 (en) 2011-11-10 2013-05-16 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
DE102012203880A1 (de) 2012-03-13 2013-09-19 Robert Bosch Gmbh Funktionspflaster mit Sensor und Aktor
US9707339B2 (en) 2012-03-28 2017-07-18 Angiodynamics, Inc. High flow rate dual reservoir port system
US9713704B2 (en) 2012-03-29 2017-07-25 Bradley D. Chartrand Port reservoir cleaning system and method
DE102012205745A1 (de) 2012-04-10 2013-10-10 Robert Bosch Gmbh Elektronische Pflastervorrichtung mit wenigstens einer Energiequelle
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
CA2924141C (en) 2013-08-22 2022-06-07 The General Hospital Corporation 5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
CA2922361C (en) 2013-08-29 2022-07-12 Trustees Of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
US20150147555A1 (en) * 2013-11-23 2015-05-28 Orahealth Corporation Multilayer mucoadhering patch with a nonadhering layer comprising casein
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
WO2016025329A1 (en) 2014-08-15 2016-02-18 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
WO2016196664A1 (en) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Methods and use of compounds that bind to rela of nf-kb
RU2018107227A (ru) 2015-07-28 2019-08-28 Виоме Терапьютикс Лимитед Терапевтические и профилактические антибактериальные средства
EP3411110B1 (en) * 2016-02-05 2020-08-05 PassPort Technologies, Inc. Transdermal permeant application device
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited DRUG DELIVERY METHODS AND SYSTEMS

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US351233A (en) * 1886-10-19 Henry w
US486902A (en) * 1892-11-29 Galvanic body-battery
US385556A (en) * 1888-07-03 Medicated electric belt
US770014A (en) * 1904-09-13 Electfiomedical
US857664A (en) * 1907-01-10 1907-06-25 David R Overman Electromedical appliance.
US2301567A (en) * 1940-12-04 1942-11-10 Charles O Morse Allergen applicator and skin tester
US2667162A (en) * 1950-05-03 1954-01-26 Zwahlen Henry Device permitting the ambulatory ionization of blood circulatory troubles of the lower limbs
US2784715A (en) * 1953-03-25 1957-03-12 Kestler Otto Colman Cataphoresis unit
US4166457A (en) * 1976-08-16 1979-09-04 University Of Utah Research Institute Fluid self-sealing bioelectrode
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4856188A (en) * 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5224928A (en) * 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US5135479A (en) * 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4911688A (en) * 1986-07-15 1990-03-27 Patent Research And Development Corp. Fluid containing covers - with electrical circuits
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
US5195953A (en) * 1988-04-21 1993-03-23 Demartini Richard J Method of increasing skin absorption of a drug
US4997418A (en) * 1988-04-21 1991-03-05 C. P. Chambers Epidermal iontophoresis device
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
IT1244030B (it) * 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
WO1991015261A1 (en) * 1990-03-30 1991-10-17 Medtronic, Inc. Activity controlled electrotransport drug delivery device
US5037381A (en) * 1990-07-27 1991-08-06 Bock C Randolph Electrically assisted transdermal transport device and method for renewing the device
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) * 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5246418A (en) * 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
AU676711B2 (en) * 1992-12-31 1997-03-20 Alza Corporation Electrotransport system having flexible means
US5458569A (en) * 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
FR2709670B1 (fr) * 1993-09-10 1995-10-20 Asulab Sa Dispositif en trois modules pour l'administration transdermique de médicaments par électrophorèse ou iontophorèse.
US5498235A (en) * 1994-09-30 1996-03-12 Becton Dickinson And Company Iontophoresis assembly including patch/controller attachment

Also Published As

Publication number Publication date
JPH11503037A (ja) 1999-03-23
WO1996030077A1 (en) 1996-10-03
DE69613113D1 (de) 2001-07-05
EP0817659B1 (en) 2001-05-30
EP0817659A1 (en) 1998-01-14
DE69613113T2 (de) 2002-03-21
ATE201604T1 (de) 2001-06-15
PT817659E (pt) 2001-09-28
ES2159022T3 (es) 2001-09-16
ZA962122B (en) 1996-09-26
US5879322A (en) 1999-03-09
DK0817659T3 (da) 2001-08-06

Similar Documents

Publication Publication Date Title
GR3036450T3 (en) Self-contained transdermal drug delivery device
ATE238821T1 (de) Ausrüstung enthaltend eine implantierbare vorrichtung
EP0714316A4 (en) IMPLANTABLE MEANS FOR THE ADMINISTRATION OF MEDICINES
GR3029963T3 (en) Transdermal active-substance preparation
GB0123381D0 (en) Factor
IL100487A0 (en) Method and composition for disinfecting contact lenses
EP0663126A4 (en) DEVICE FOR PRODUCING TELEPHONE CONNECTIONS.
EP0708627A4 (en) METHOD AND DEVICE FOR THE TRANSDERMAL OR TRANSBUCCAL THERAPEUTIC ADMINISTRATION OF NICOTINE SUBSTITUTES
EP0965216A4 (en) INTERNET / INTRANET TELEPHONE SYSTEM
AU8946191A (en) Device for use in laser angioplasty
EP0908186A3 (en) Method for treating pain
GR3015017T3 (en) Integrating laser diode pumped laser apparatus.
AU3048495A (en) Passive lubrication delivery system and integral bearing housing
AU584909B2 (en) Method for decontaminating and cleaning ocular prosthesis, particularly contact lenses, and device for implementing such method
EP1634605A3 (en) treatment of dyslipidemia in a patient having type 2 diabetes
GB9417749D0 (en) Portable cleaning apparatus
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
WO2000038620A3 (en) A composition useful to treat periodontal disease
DK0723517T3 (da) Indretning til indføring i en beholder og til at forhindre indretningens fjernelse fra beholderen
EP0666279A3 (en) Polymethyl-3,3,3-trifluoropropylsiloxane elastomers, stress crystallizable and process for their preparation.
GB9621366D0 (en) Stacked component tapered bearing simulator device
USD388866S (en) Bath leg relaxation/support device
FR2740623B1 (fr) Manchon pour le logement d'un quelconque appareil, en particulier d'un appareil electrique, et poincon pour le moulage d'un tel manchon
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU649750B2 (en) Pressure oxidation methods for gold extraction and toxic waste treatment

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20111004